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Abstract
Background: Adolescents are considered at high risk of developing iron deficiency. Studies in children indicate
that the prevalence of iron deficiency increased with malaria transmission, suggesting malaria seasonally may drive
iron deficiency. This paper examines monthly seasonal infection patterns of malaria, abnormal vaginal flora,
chorioamnionitis, antibiotic and antimalarial prescriptions, in relation to changes in iron biomarkers and nutritional
indices in adolescents living in a rural area of Burkina Faso, in order to assess the requirement for seasonal infection
control and nutrition interventions.
Methods: Data collected between April 2011 and January 2014 were available for an observational seasonal
analysis, comprising scheduled visits for 1949 non-pregnant adolescents (≤19 years), (315 of whom subsequently
became pregnant), enrolled in a randomised trial of periconceptional iron supplementation. Data from trial arms
were combined. Body Iron Stores (BIS) were calculated using an internal regression for ferritin to allow for
inflammation. At recruitment 11% had low BIS (< 0 mg/kg). Continuous outcomes were fitted to a mixed-effects
linear model with month, age and pregnancy status as fixed effect covariates and woman as a random effect.
Dichotomous infection outcomes were fitted with analogous logistic regression models.
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Results: Seasonal variation in malaria parasitaemia prevalence ranged between 18 and 70% in non-pregnant
adolescents (P < 0.001), peaking at 81% in those who became pregnant. Seasonal variation occurred in antibiotic
prescription rates (0.7–1.8 prescriptions/100 weekly visits, P < 0.001) and chorioamnionitis prevalence (range 15–
68%, P = 0.026). Mucosal vaginal lactoferrin concentration was lower at the end of the wet season (range 2–22 μg/
ml, P < 0.016), when chorioamnionitis was least frequent. BIS fluctuated annually by up to 53.2% per year around
the mean BIS (5.1 mg/kg2, range 4.1–6.8 mg/kg), with low BIS (< 0 mg/kg) of 8.7% in the dry and 9.8% in the wet
seasons (P = 0.36). Median serum transferrin receptor increased during the wet season (P < 0.001). Higher hepcidin
concentration in the wet season corresponded with rising malaria prevalence and use of prescriptions, but with no
change in BIS. Mean Body Mass Index and Mid-Upper-Arm-Circumference values peaked mid-dry season (both P <
0.001).
Conclusions: Our analysis supports preventive treatment of malaria among adolescents 15–19 years to decrease
their disease burden, especially asymptomatic malaria. As BIS were adequate in most adolescents despite seasonal
malaria, a requirement for programmatic iron supplementation was not substantiated.
Keywords: Season, Adolescents, iron biomarkers, Malaria, Abnormal vaginal flora, Bacterial vaginosis, Body mass
index, MUAC, Burkina Faso
Introduction
Seasonality defines the epidemiology of malaria and is
observed for almost all infectious diseases, denoting cyc-
lical changes in exposure and host immunity [1–3].
Studies in children showed prevalence of iron deficiency
increased over the malaria season, [4] but decreased
when malaria transmission was interrupted by vector
control, [5] suggesting malaria was seasonally driving
iron deficiency. The mechanism responsible for this
interaction was hepcidin. This hormone, when stimu-
lated by inflammation due to malaria or respiratory in-
fection in young children, restricts enteric iron
absorption and, by limiting iron availability, may lead to
iron deficiency [6, 7].
Whether malaria drives seasonal iron deficiency in ad-
olescents is an important question, given their continu-
ing exposure to malaria and multiple other infections,
alongside increased iron requirements for growth and
maturation. In Burkina Faso, higher body iron stores
(BIS) in adolescents predicted an increased malaria risk
in the following rainy season approximately 5 months
later, [8] as well as in early pregnancy in those who went
on to conceive [9]. Preterm birth incidence showed a
striking seasonal pattern, with a 50% increased effect size
in iron supplemented women [10]. An inhibitory effect
of iron on nitric oxide, interfering with macrophage-
mediated action against Plasmodium [11], as well as the
parasite’s own capacity to acquire iron as a means to in-
crease pathogenicity [12], may explain the higher malaria
risk with elevated iron levels. Median levels of serum
hepcidin were significantly higher in the presence of
malaria parasitaemia in non-pregnant and pregnant ado-
lescents, which could reduce iron absorption to reverse
some of these effects [13]. Of interest was hepcidin up-
regulation with lower genital tract infection. Concentra-
tions of lactoferrin (Lf), which binds free iron in genital
mucosa, rose in the presence of lower tract infections
capable of causing chorioamnionitis, and positively cor-
related with serum hepcidin, serum ferritin and BIS [14].
Iron deficient adolescents were more likely to have nor-
mal vaginal flora [15]. These observations suggest that
infection prevalence at a given time point is confounded
by prior iron deficiency or repletion, which itself may be
seasonally governed.
Seasonal studies on adolescents are lacking yet under-
standing seasonal infection patterns should provide a
basis for timely selection of interventions to reduce ado-
lescent morbidity and mortality, especially before a first
pregnancy. To date, malaria seasonality has been inter-
preted mostly in relation to vector parameters and age-
specific parasite prevalence [16]. Seasonal malaria-iron
studies conducted in young children have relied on ob-
servations recorded at the start and end of the wet sea-
son, with events not measured during interim periods or
between seasons [17]. This paper examines monthly sea-
sonal infection patterns of malaria, abnormal vaginal
flora, chorioamnionitis, antibiotic and antimalarial pre-
scriptions, in relation to changes in iron biomarkers and
nutritional indices in adolescents living in a rural area of
Burkina Faso, in order to assess the requirement for sea-
sonal infection control and nutrition interventions. Data
had been collected over a 32-month period, as part of a
community-based randomised controlled trial in adoles-
cents of weekly iron supplementation [13].
Methods
The community based randomised controlled trial of
iron supplements (weekly ferrous gluconate (60 mg) with
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folic acid (2.8 mg) as intervention or folic acid alone as
control) was approved by ethical review boards at collab-
orating centres and registered with clinicaltrials.gov:
NCT01210040 (Additional file 1). Participants were re-
cruited as healthy, nulliparous, non-pregnant women
aged 15–24 years from thirty rural villages located within
the Health Demographic Surveillance System of the
Clinical Research Unit in Nanoro in rural Burkina Faso,
[13] and followed weekly. Individual/guardian written
consents were obtained from participants at recruitment.
HIV prevalence was low (< 2%). Malaria is hyperen-
demic, with the main rainfall (daily chance of precipita-
tion above 20%) from May to mid-October [18]. Food
shortages occur from June to August (lean season), cor-
responding to the early rainy season, with food abun-
dance post-harvest around November to December [19].
All participants were treated with albendazole and prazi-
quantel at enrolment and provided with an insecticide
impregnated bed net.
Between April 2011 and January 2014 data were col-
lected at several study assessment points and at weekly
follow-up visits. The present analysis included young
menarcheal women at baseline who remained non-
pregnant until the end of the trial, as well as data from
those who became pregnant during the 18-month sup-
plementation period and had re-consented at entry to
the pregnancy cohort (Additional file 1). They were
monitored until delivery and their babies followed up to
2 years of age [20]. As there were no significant or sub-
stantive differences in iron biomarker profiles between
arms at trial end-points, [13] data from both arms were
pooled for the present analysis.
Non-pregnant cohort assessments
Baseline: Recruitment extended over 9 months. Demo-
graphic data, dietary information and medical histories,
including last menstrual period and age at menarche,
were collected and a clinical examination performed
[13]. Height (nearest mm) and weight (nearest 100 g) for
Body Mass Index (BMI) and mid-upper arm circumfer-
ence (mm: MUAC) were measured in duplicate. A ven-
ous blood sample (5 ml) was collected for later iron
biomarker assessments [13]. Self-taken vaginal swabs
were requested for bacterial vaginosis (BV), gram stain,
pH and Lf assays as previously described [14, 15]. Gram
stains were scored using Nugent criteria with 7–10 indi-
cating BV, 4–6 intermediate and 0–3 normal flora.
For trial design reasons, malaria parasitaemia and
haemoglobin were not measured at baseline, although
women symptomatic for malaria were treated in line
with government guidelines (artesunate-amodiaquine or
arthemeter-lumefantrine, or rescue treatment with quin-
ine). Clinical malaria (axillary temperature ≥ 37.5 °C and/
or history of fever within last 48 h) was confirmed by
rapid diagnostic test (RDT). At the weekly visits which
followed recruitment, participants symptomatic with
malaria or other infections were referred to local health
centres for free treatment and reasons for treatment
were recorded. Missed periods were followed up with a
urine pregnancy test.
End Assessment (FIN): Final assessments were made
after 18 months of supplementation when procedures
for nutritional and iron biomarker assessments at enrol-
ment were repeated. Malaria parasitaemia was assessed
and women with positive results were treated.
Pregnant cohort assessments
At a first antenatal visit (ANC1) scheduled for 13–16
weeks gestation, in addition to standard antenatal care
(including daily iron and folic acid for all participants
and administration of intermittent preventive malaria
treatment at relevant gestational dates) a blood sample
(5 ml) was obtained for iron biomarkers and malaria mi-
croscopy. Self-taken vaginal swabs were requested, as for
the non-pregnant cohort [15]. BMI and MUAC were
measured. The pregnant cohort continued with weekly
follow-up and referral for free treatment for symptom-
atic illness until delivery, when placentae were collected,
if available, to determine placental malaria and chor-
ioamnionitis [10].
Laboratory procedures
These have been previously described, [13, 14] and a
technical resumé is provided in Additional file 2. Blood
was assayed for plasma ferritin, serum transferrin recep-
tor (sTfR), hepcidin and C-reactive protein (CRP). A
non-pregnant internal regression slope log (ferritin)
against log CRP estimate was used for ferritin correction
[21]. Iron stores were calculated using the regression-
adjusted ferritin estimate. Low BIS were defined as zero
iron stores < 0 mg/kg. BIS (mg/kg) were calculated using
the equation derived by Cook et al.: body iron (mg/kg) =
− [log10 (1000 × sTfR/ferritin) – 2.8229]/0.1207 [22].
Hepcidin assays were performed at the Department of
Laboratory Medicine, Radboud University Nijmegen
Medical Center, The Netherlands [23]. Malaria films
using whole blood were Giemsa stained and read by two
qualified microscopists. For discrepant findings (posi-
tive/negative; > two-fold difference for parasite densities
≥400/μl; > log10 if < 400/μl), a third independent reading
was made. Duplicate Lf samples were processed and
analysed independently. Lf was measured by ELISA and
measurements standardised for duplicate samples and
sample weight [14]; the geometric mean is presented
here. Gram stains were sent for Nugent scoring to the
Microbiology Department at Manchester University
NHS Foundation Trust, UK. Abnormal flora are defined
as Nugent scores 4–10.
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Statistical analysis
The sample available was determined by the size of
the trial which was sized using formal power calcula-
tions for the scheduled malaria endpoint [13], which
for pregnant women was at ANC1. Continuous out-
comes, based on scheduled visits, were fitted to a
mixed-effects linear model with month (1 to 12), age
(centred at the median age of 17 years), and preg-
nancy status as fixed effect covariates and woman as
a random effect. This allowed correlation between re-
peat measurements in the same women and increased
the power of the analysis by exploiting the within-
women differences across seasons. Effects were plot-
ted adjusted for age and pregnancy and represent
non-pregnant women at age 17 years. 95%CI (Confi-
dence intervals) were computed using a profile likeli-
hood method. Amplitude of the seasonal effect was
estimated as the difference between the largest and
smallest monthly coefficients. The peak and nadir
were determined by the months with the largest and
smallest monthly coefficients. CI for the amplitude
and peak/nadir months were derived using bootstrap-
ping. Where appropriate the outcomes were log-
transformed for analysis, and coefficients and ampli-
tudes are presented on this log scale.
Dichotomous infection outcomes were fitted with
analogous logistic regression models, but as there were
insufficient repeat measurements to fit a random woman
effect, standard fixed-effect models are presented, with
coefficients expressed as odds ratios. Seasonal amplitude
is presented as the difference between the event rates in
the highest and lowest months, after adjusting for age
and pregnancy effects.
Prescription data were aggregated into the number
of prescriptions dispensed per month and fitted using
a Poisson regression model. Consideration of individ-
ual level covariates was precluded as appropriate de-
nominators were not known. The number at risk was
estimated by the number of recorded contacts (weekly
home plus unscheduled health centre visits) and thus
approximate to person-weeks of exposure. CI for sea-
sonal amplitude, peak and nadir months were esti-
mated by simulating monthly totals from a Poisson
distribution using the estimated rates and numbers at
risk. Seasonal amplitude is presented as the difference
between event rates in the highest and lowest
months.
For comparison annual means were estimated as sim-
ple means (geometric means for log-transformed out-
comes) of the 12 monthly coefficients. We also present
standard deviations (again log-transformed where appro-
priate) between observations for the continuous out-
comes to provide context for the observed seasonal
amplitudes.
Results
Table 1 lists data sources and numbers of assessments
available at baseline and end assessment for non-
pregnant women, at ANC1 for pregnant women and at
weekly visits. In total 1949 women contributed some
data to the study. Of these 93.3% were adolescent, with
only 130 more than 19 years and none less than 15 years
old. All were menarcheal and nulliparous at enrolment
and 315 women who became pregnant during follow-up
were assessed at ANC1. At 102452 weekly follow-up
visits of 1897 women, including some unscheduled visits,
1.3% were prescribed free antibiotics for mainly dysen-
teric symptoms, and 2.1% free antimalarials for clinical
malaria. Distribution of attendances is shown in Fig. 1,
with months and years of attendance for the assessment
points. The total monthly attendances over 12 months
were spread across wet and dry seasons. Fewer non-
pregnant attendances in September and October were
recorded.
Seasonal infection patterns
Combined non-pregnant and pregnant monthly preva-
lence estimates for malaria parasitaemia and for genital
bacterial flora with a Nugent score ≥ 4 are shown in
Fig. 2, together with frequency of prescriptions for anti-
biotics and antimalarials. Malaria parasitaemia preva-
lence showed highly significant seasonal variation (P <
0.001), with a wet season September peak of 70% in
non-pregnant women and a single dry season nadir in
May of 18%. The September peak malaria prevalence for
pregnant women in early pregnancy at ANC1 was 81%.
The odds ratio for increased malaria infection in preg-
nancy was 1.9 (95%CI 1.3–2.6) (Table 2). Antimalarials
for clinical cases were more frequently prescribed in the
middle of the wet season with an August peak (P <
0.001), although malaria prevalence remained above 40%
for 4 months into the dry season.
Prevalence of abnormal vaginal bacterial flora was uni-
form through the dry season with a mean value of 23%,
with higher prevalence of 38% at the end of the wet season
(P = 0.28). There were no significant effects of age or preg-
nancy status on prevalence of abnormal vaginal flora. Pre-
scription of antibiotics almost doubled during the wet
season (P < 0.001). Monthly prevalence of chorioamnioni-
tis is shown for 181 women with delivery placental sam-
ples. Mean chorioamnionitis prevalence was 43%, with
higher values through most of the dry season (peak June)
and a nadir at the end of the wet season (October) (P =
0.026). Table 2 summarises significance levels for seasonal
variation, along with pregnancy and age effect sizes.
Seasonal iron biomarker patterns
Monthly concentrations of iron biomarkers and CRP are
shown in Fig. 3, with a summary of significance levels
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and timing of seasonal peaks and troughs in Table 2.
Median BIS were 5.1 mg/kg2 and showed significant sea-
sonal variation (range 4.1–6.8 mg/kg) with a single No-
vember peak and April nadir, (P < 0.001). This
represents an average of 53.2% variation around mean
BIS during a 12-month period. BIS values were slightly
below the annual mean value throughout the wet season
but recovered quickly in the dry season and remained
slightly above this annual mean. However, percentages
with low BIS (< 0 mg/kg) were 9.5% in the dry season
and 9.2% in the wet season (P = 0.19), with the corre-
sponding adjusted estimates in non-pregnant women be-
ing 8.7% (dry) and 9.8% (wet) (P = 0.36), after fitting a
logistic model allowing for age and pregnancy.
Mean sTfR concentration was 6.7 μg/ml, with a single
October peak following an increase in concentration in
the last 2 months of the wet season (P < 0.001). sTfR
concentrations declined in November and December in
the early dry season when malaria prevalence was still
high. Monthly hepcidin concentrations were higher to-
wards the end of the wet season compared to dry season
values (P < 0.001). The mean value was 3.68 nmol/l, with
relatively narrow range (2.75–5.21 nmol/l). A single peak
in concentration occurred in August, with a single nadir
in January in the middle of the dry season.
Monthly vaginal Lf concentration was almost uniform
throughout the year, but with a decline in values in the
late wet season and seasonal range of 2.0–21.5 μg/ml,
P = 0.016). Seasonal effects on iron biomarkers were
small compared to the variation between individuals as
shown by their standard deviations (Table 2). CRP
concentrations were moderately raised and showed
smooth seasonal cyclic variation with a range of 0.41–
1.28 mg/l, with two nadirs in the dry season and a single
peak at the end of the wet season (P < 0.001). CI for all
biomarkers were wider for September and October due
to the smaller number of assessments available for these
months.
Anthropometric and dietary patterns
Monthly variation in BMI and MUAC are shown in
Fig. 4, with summary statistics in Table 2. Highly signifi-
cant seasonal variation was observed for both indices
(P < 0.001). Seasonal patterns for each indicator were
closely mirrored, with the same peak month (March) at
the end of the post-harvest period, and nadirs in Octo-
ber for BMI and November for MUAC at the end of the
wet season. The ranges of these changes were 19.5–20.4
kg/m2 for BMI and 23.7–24.3 cm for MUAC (both P <
0.001).
Discussion
This study assessed seasonal trends in adolescent infec-
tions, nutritional status and risk of iron deficiency over a
32-month period. The data were consistent with malaria
and other infections driving the hepcidin response to
control iron homeostasis. As a result, BIS fluctuated by
up to 53% per year around a mean of 5.5 mg/kg. Iron
stores were below the mean in the wet season but recov-
ered sharply post-harvest, at the beginning of the dry
season when food was more plentiful and workloads de-
creased. Increased prescription of antibiotics and
Table 1 Data sources and sample sizes at assessment points
Outcome Assessment
points a
Assessments Women Mean b
N N
Malaria parasite +ve ANC1, FIN 1287 1230 578 (44.9)
Antimalarial Px rate/year Weekly visits 102,452 c 1897 2120 (2.1)
Antibiotic Px rate/year Weekly visits 102,452 c 1897 1287 (1.3)
Abnormal vaginal flora +ve Baseline, ANC1, FIN 2397 1683 505 (21.1)
Chorioamnionitis +ve Delivery 181 181 80 (44.2)
BIS, mg/kg Baseline, ANC1, FIN 2594 1757 5.5 (2.8–7.6)
Hepcidin, nmol/l Baseline, ANC1, FIN 2923 1885 3.8 (1.6–8.7)
sTfR, μg/ml Baseline, ANC1, FIN 2923 1881 6.2 (5.0–7.8)
Lf, μg/ml ANC1, FIN 1048 999 9.85 (2.85–61.17)
CRP, mg/l Baseline, ANC1, FIN 2926 1884 0.631 (0.224–1.937)
MUAC, cms Baseline, ANC1, FIN 2956 1898 24.1 (22.9–25.4)
BMI, kg/m2 Baseline, ANC1, FIN 2956 1897 20.2 (19.0–21.6)
BIS Body iron stores, sTfR Serum transferrin receptor, Lf Vaginal lactoferrin, CRP C-reactive protein, BMI Body Mass Index, MUAC Mid-upper-arm-circumference, Px
Prescription of drug
aBaseline survey in non-pregnant women; end assessment survey in non-pregnant women (FIN)
First antenatal visit survey (ANC1) and weekly visits
bN (%) dichotomous variables; median (IQR) for continuous variables; N (rate) for prescription (Px) rate
cWeekly visits include some unscheduled visits
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antimalarials in the wet season reflected higher infection
risk, which may partly relate to reduced immunity with
poorer diet, [24] and increased malaria exposure.
The finding that ~ 75% of all those followed were
parasitaemic at the peak of the wet season is a clear indi-
cator of the need to lower wet season malaria transmis-
sion in this older age group. We have previously
reported a high risk of adverse birth outcomes in the
same adolescents, [10] and an increased risk of malaria
in their infants [20]. Elevated hepcidin values in the dry
season suggest that chronic asymptomatic infections are
carried over from the wet season and contribute to these
outcomes. In this study, 96% of malaria infections in
non-pregnant and pregnant women were asymptomatic
Fig. 1 Numbers of assessments by time at the four assessment points and weekly visits. Left hand panels show the visit dates and the right hand
panels the calendar months. Yellow: dry season months; blue: wet season months
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Fig. 2 Monthly fitted estimates for infection parameters. Models fitted to all data adjusted for age and pregnancy status. Error bars represent 95%
CI. Yellow: dry season months; blue: wet season months. Horizontal line is annual mean. Lines are fitted estimates and represent values for non-
pregnant women of median age 17 years
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[13]. Asymptomatic P.falciparum parasitaemias in young
pregnant women are also described in Mali, Ghana and
Gambia [25], but pregnant women are easier to reach
for treatment than non-pregnant adolescents. School-
based intervention programmes for 5 to 15 year old chil-
dren [26–28] may be feasible, but would not cover the
older age group in our study. In Burkina Faso, secondary
school enrolment for both sexes in 2019 was just 43%
[29]. Making services more accessible to adolescents
would be helpful, especially for symptomatic gastrointes-
tinal and respiratory problems, but asymptomatic mal-
aria and genital infections would still be missed.
Seasonal malaria chemoprevention of children less
than 6 years is recommended by the World Health
Organization and is being widely implemented in com-
munity settings in West Africa, including Burkina Faso
[30]. It requires monthly administration of a full course
of antimalarials during the malaria season and is effect-
ive in reducing morbidity and mortality by maintaining
therapeutic drug concentrations in the blood [31]. Re-
search is needed to address the feasibility and cost ef-
fectiveness of a similar community-based approach for
seasonal prevention of malaria in older adolescents,
some of whom could be unknowingly pregnant. Clinicals
trials would be required, keeping in mind that the anti-
malarial treatment recommended by the World Health
Organization for first trimester pregnancy would be dif-
ficult to implement in the adolescent population, most
of whom would not be pregnant. Current WHO guide-
lines recommend 7 days of quinine plus clindamycin,
twice daily, for uncomplicated P. falciparum malaria
during the first trimester [30]. Yet an Evidence Review
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BIS Body iron stores, sTfR Serum transferrin receptor, Lf Vaginal lactoferrin, CRP C-reactive protein, BMI Body Mass Index, MUAC mid-upper-arm-circumference, Px
Prescription of drug
aMean is value averaged over the whole year
bSD is the standard deviation of the raw data for the continuous variables on a log-scale for transformed outcomes to allow comparison with effect sizes and
amplitude of seasonal effects
cEffect sizes are differences or differences in log-transformed values for continuous variables and odds ratios for dichotomous
variables. Brackets are 95% CI
dMinimum to maximum seasonal range. For log-transformed variables this corresponds to a proportional variation around a mean value
eAmplitude is the peak-nadir difference after adjusting for age and pregnancy effects. For log transformed variables this is the difference on a log-scale
fAntibiotics and antimalarials are unadjusted estimates (see methods)
gPeak/nadir not well defined due to multiple or very broad peaks/troughs
hLog-transformed
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Fig. 3 Monthly fitted estimates for iron biomarkers and C-reactive protein. Models fitted to all data adjusted for age and pregnancy status. Error
bars represent 95% CI. Yellow: dry season months; blue: wet season months. Horizontal line is annual mean. Lines are fitted estimates and
represent values for non-pregnant women of median age 17 years
Roberts et al. BMC Public Health         (2021) 21:1764 Page 9 of 13
Group convened by WHO’s Global Malaria Programme
concluded that artemisinin combination treatments
(ACTs) should be used to treat uncomplicated falcip-
arum malaria in the first trimester [32]. Their use in any
trimester in human pregnancy has not been associated
with increased risk of miscarriage, stillbirth or congenital
abnormality compared to those treated with quinine, or
to the background population level of these outcomes
[33]. Clinical trials of ACTs in non-pregnant adolescents
should screen for pregnancy to indicate the level of ac-
ceptability of routine pregnancy testing and to exclude
first trimester exposures with a seasonal malaria
programme using ACTs.
Hepcidin levels were highest in August, a month
before peak malaria prevalence, and did not rise fur-
ther despite continued malaria transmission in the
dry season. An inflammatory signal denoted by rising
CRP concentrations at the start of the wet season was
positively associated with rising hepcidin and decreas-
ing CRP concentrations in the late wet season with
lower hepcidin values. These stabilised around a mean
of 3.7 nM/l (Table 2), considerably higher than the
2.6 nM/l median reference values for healthy western
women (18–24 years), using the same assay [23]. In
young non-pregnant Beninese women with
asymptomatic parasitaemias, a ~ 40% reduction in iron
absorption occurred at similar hepcidin levels to those
reported here [34], and being persistently raised,
would anticipate an increased risk of iron deficiency.
Yet a decline in BIS levels did not occur until four to
5 months after the hepcidin peak and were lowest in
April, mid-dry season. Mean BIS estimates were com-
parable to those reported for first trimester American
women in the NHANES survey (6.28 mg/kg), and for
Vietnamese non-pregnant women (4.7 mg/kg) [9].
The sTfR response was highest at the end of the wet
season, a month following the peak values for malaria
prevalence, CRP and hepcidin. A rise in sTfR is the ini-
tial intracellular response to a reduction in iron supply,
indicating a degree of functional iron depletion and an
erythropoietic response [35]. These sTfR concentrations
declined in the early dry season, when malaria preva-
lence was still high, suggesting only a short period of
malaria-related functional iron depletion, with no obvi-
ous need for ongoing iron supplementation. The prob-
lem is that iron interventions for adolescents are largely
based on anaemia prevalence [36]. In a previous paper
we reported an end assessment anaemia prevalence
(Hb < 12 g/dl) of 43.4% in the non-pregnant cohort [9].
This is a level at which iron-containing supplementation
Fig. 4 Monthly fitted estimates for BMI and MUAC. Models fitted to all data adjusted for age and pregnancy status. Error bars represent 95% CI.
Yellow: dry season months; blue: wet season months. Horizontal line is annual mean. Lines are fitted estimates and represent values for non-
pregnant women of median age 17 years
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of adolescents is recommended, including iron fortified
food, multiple micronutrients, and lipid-based nutrient
supplements [36]. None of these would be recom-
mended in Burkina Faso, given the lack of an effective
adolescent malaria control strategy, as well as availability
of alternative dietary iron sources. Across this region,
sorghum is a major contributor to dietary iron intakes
across wet and dry seasons, with post-harvest crops in-
creasing dietary diversity and providing more sources of
iron [37, 38]. Traditional sorghum beer, consumed
widely in Burkina Faso [39], and other areas with limited
resources, also contributes to micronutrient adequacy in
the diet [40].
The higher prevalence of abnormal vaginal flora in
September and October was not statistically significant,
although its occurrence corresponded with a significant
peak in vaginal Lf concentration in October. This may
indicate a local mucosal immune response to genital in-
fection, [41] but it was not associated with hepcidin up-
regulation in the same months. Lf concentrations
declined over the wet season as did BMI and MUAC.
We have previously reported a significant positive asso-
ciation of vaginal Lf with MUAC and BMI in this popu-
lation [14] and these nutritional indices declined
throughout the wet season. Targeted seasonal measures
to redress this might be warranted but relevant interven-
tions have not been addressed [42]. General measures to
improve community food security, such as reducing
post-harvest food storage losses, would benefit adoles-
cents [43]. Malaria chemoprevention should have syner-
gistic effects in decreasing anaemia [26].
It is of interest that peak prevalence of chorioamnioni-
tis occurred approximately 5 months following the
higher prevalence of abnormal vaginal flora. Chorioam-
nionitis risk was highest when women were less likely to
receive anti-malarials or antibiotics. Risk of chorioam-
nionitis may relate to early gestational exposure to ab-
normal flora and ascending chronic infection established
in the wet season.
The main strength of this study was the large sample
and weekly follow-up. Within the demographic surveil-
lance area, all health care contacts could be readily mon-
itored although diagnosis of dysentery was based on
symptoms and not confirmed by bacteriology. The trial
was not designed to assess seasonal effects, but close
follow-up of participants allowed collection of infection
treatment data, across clearly defined seasons, not solely
at study endpoints. Haemoglobin was not measured at
baseline when iron biomarkers were assessed, and diet-
ary data were not collected at study endpoints. The rural
location represented a high malaria transmission area
with well-defined seasonality, common to the sub-
Sahelian region. Mid-wet season data came mainly from
pregnant women, as non-pregnant adolescents were
generally absent from home for planting/harvesting. As
a result, separate seasonal effects in pregnant and non-
pregnant women could not be ascertained and constant
pregnancy effects throughout the year were assumed,
with seasonal effects adjusted for age and pregnancy co-
variates. Geographical variations in exposures to patho-
gens or diet may have confounded seasonal effects as
trial recruitment was conducted sequentially across vil-
lages, but these biases are likely to be negligible.
Conclusions
Seasonal analysis is very useful for rationalising delivery
of adolescent interventions. Malaria seasonal chemopre-
vention for this age-group should be evaluated in clinical
trials to target their high prevalence of asymptomatic
and chronic P.falciparum infections. In terms of the
need for adolescent iron supplementation, this seasonal
analysis showed iron stores were satisfactory at the
population level and were largely maintained by host
mechanisms, despite seasonal dietary changes. Some in-
dividuals would benefit from additional iron for specific
clinical reasons, but this would not justify programmatic
roll-out of iron supplementation. Whether improved nu-
trition would increase immunity to lower genital tract
infections is an area for future research.
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